BRPI1013548B8 - método de purificação industrial de ficotoxinas biologicamente ativas - Google Patents
método de purificação industrial de ficotoxinas biologicamente ativasInfo
- Publication number
- BRPI1013548B8 BRPI1013548B8 BRPI1013548A BRPI1013548A BRPI1013548B8 BR PI1013548 B8 BRPI1013548 B8 BR PI1013548B8 BR PI1013548 A BRPI1013548 A BR PI1013548A BR PI1013548 A BRPI1013548 A BR PI1013548A BR PI1013548 B8 BRPI1013548 B8 BR PI1013548B8
- Authority
- BR
- Brazil
- Prior art keywords
- phycotoxins
- biologically active
- previous step
- eluate
- industrial purification
- Prior art date
Links
- 231100000769 Phycotoxin Toxicity 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 4
- 238000000746 purification Methods 0.000 title abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 239000005909 Kieselgur Substances 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000008346 aqueous phase Substances 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 2
- 239000006228 supernatant Substances 0.000 abstract 2
- 230000009089 cytolysis Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
método de purificação industrial de ficotoxinas biologicamente ativas. esta invenção relaciona-se com um método de purificação industrial de ficotoxinas biologicamente ativas que permite proporcionar uma quantidade adequada de ficotoxinas; se a fonte de ficotoxinas for um pellet, ele é submetido à lise usando método apropriados; o material proveniente das lises de cianobactérias é submetido a uma extração a frio; obter um concentrado da fase aquosa obtida na etapa anterior ou do meio de cultura da primeira etapa; centrifugar o concentrado para obter um sobrenadante; passar o sobrenadante por uma coluna de terras de diatomáceas e obter um eluído da ficotoxina; o eluído obtido no passo anterior é passado por colunas de carvão ativado; o eluído da etapa anterior novamente é passado por uma coluna de terras de diatomáceas; o eluído da etapa anterior é colocado em fase aquosa; o extrato parcialmente purificado da etapa anterior é submetido à hplc preparado em vários passos, obtendo a ficotoxina biologicamente ativa pura.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2009000723A CL2009000723A1 (es) | 2009-03-24 | 2009-03-24 | Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias. |
| PCT/IB2010/051187 WO2010109386A1 (es) | 2009-03-24 | 2010-03-18 | Método de purificación industrial de ficotoxinas biológicamente activas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1013548A2 BRPI1013548A2 (pt) | 2016-09-20 |
| BRPI1013548B1 BRPI1013548B1 (pt) | 2020-06-09 |
| BRPI1013548B8 true BRPI1013548B8 (pt) | 2021-05-25 |
Family
ID=42780210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013548A BRPI1013548B8 (pt) | 2009-03-24 | 2010-03-18 | método de purificação industrial de ficotoxinas biologicamente ativas |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2412714B9 (pt) |
| JP (1) | JP5728774B2 (pt) |
| KR (1) | KR20110130420A (pt) |
| AR (1) | AR075931A1 (pt) |
| BR (1) | BRPI1013548B8 (pt) |
| CA (1) | CA2754154C (pt) |
| CL (1) | CL2009000723A1 (pt) |
| DK (1) | DK2412714T5 (pt) |
| ES (1) | ES2562637T3 (pt) |
| HR (1) | HRP20160079T1 (pt) |
| HU (1) | HUE027480T2 (pt) |
| MX (1) | MX2011010005A (pt) |
| PE (1) | PE20110903A1 (pt) |
| WO (1) | WO2010109386A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8957207B2 (en) | 2009-03-24 | 2015-02-17 | Proteus S.A. | Methods for producing phycotoxins |
| RS58750B1 (sr) | 2013-03-15 | 2019-06-28 | Childrens Medical Ct Corp | Kombinovane formulacije neosaksitoksina za produženu lokalnu anesteziju |
| US9902625B2 (en) | 2014-09-03 | 2018-02-27 | International Business Machines Corporation | Removal of HAB-produced toxins from bodies of water |
| GB201602576D0 (en) | 2016-02-12 | 2016-03-30 | Bergen Teknologioverforing As | Process |
| CN107602580B (zh) * | 2017-09-08 | 2019-06-11 | 浙江理工大学 | 一种聚酮类化合物及其制备方法和应用 |
| CN109142595A (zh) * | 2018-08-23 | 2019-01-04 | 中国水产科学研究院黄海水产研究所 | 一种麻痹性贝类毒素标准溶液的制备方法 |
| US12018034B2 (en) | 2018-09-21 | 2024-06-25 | The Cawthron Institute Trust Board | Semisynthetic methods of preparing GTX1,4 and neosaxitoxin |
| EP3853231A4 (en) * | 2018-09-21 | 2022-05-11 | The Cawthron Institute Trust Board | PREPARATIVE SCALE CONVERSION OF GONYAUTOXINS TO NEOSAXITOXIN |
| WO2020058750A1 (en) * | 2018-09-21 | 2020-03-26 | The Cawthron Institute Trust Board | A semisynthetic method of preparing neosaxitoxin |
| CN114657222A (zh) * | 2022-04-08 | 2022-06-24 | 湖北省水利水电科学研究院 | 一种从水华束丝藻中提取类菌胞素氨基酸的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001413A (en) | 1973-06-12 | 1977-01-04 | Astra Pharmaceutical Products, Inc. | Pharmaceutical local anesthetic composition employing saxitoxin |
| WO1998043619A2 (en) * | 1997-04-02 | 1998-10-08 | The Regents Of The University Of California | Method of local anesthesia |
| MXPA04004543A (es) * | 2001-11-15 | 2005-03-31 | Micro Algae Corp | Composiciones farmaceuticas que contienen 3,4-propinoperhidropurinas y sus usos para el bloqueo de la transmision neuronal. |
| JP2007536269A (ja) * | 2004-05-07 | 2007-12-13 | ファイトトックス リミテッド | ゴニオトキシンを用いた創傷の治療方法 |
| DE102006028817A1 (de) * | 2006-06-21 | 2007-12-27 | Evonik Degussa Gmbh | Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen |
-
2009
- 2009-03-24 CL CL2009000723A patent/CL2009000723A1/es unknown
-
2010
- 2010-03-18 MX MX2011010005A patent/MX2011010005A/es active IP Right Grant
- 2010-03-18 HR HRP20160079TT patent/HRP20160079T1/hr unknown
- 2010-03-18 EP EP10755518.7A patent/EP2412714B9/en active Active
- 2010-03-18 BR BRPI1013548A patent/BRPI1013548B8/pt active IP Right Grant
- 2010-03-18 JP JP2012501444A patent/JP5728774B2/ja active Active
- 2010-03-18 HU HUE10755518A patent/HUE027480T2/en unknown
- 2010-03-18 WO PCT/IB2010/051187 patent/WO2010109386A1/es not_active Ceased
- 2010-03-18 PE PE2011001285A patent/PE20110903A1/es active IP Right Grant
- 2010-03-18 ES ES10755518.7T patent/ES2562637T3/es active Active
- 2010-03-18 CA CA2754154A patent/CA2754154C/en active Active
- 2010-03-18 DK DK10755518.7T patent/DK2412714T5/en active
- 2010-03-18 KR KR1020117021288A patent/KR20110130420A/ko not_active Ceased
- 2010-03-23 AR ARP100100934A patent/AR075931A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011010005A (es) | 2011-10-10 |
| AR075931A1 (es) | 2011-05-04 |
| CL2009000723A1 (es) | 2009-06-19 |
| EP2412714B9 (en) | 2016-11-23 |
| EP2412714A4 (en) | 2012-10-10 |
| CA2754154C (en) | 2013-12-17 |
| DK2412714T5 (en) | 2017-02-27 |
| WO2010109386A1 (es) | 2010-09-30 |
| EP2412714A1 (en) | 2012-02-01 |
| JP5728774B2 (ja) | 2015-06-03 |
| KR20110130420A (ko) | 2011-12-05 |
| HRP20160079T1 (hr) | 2016-04-08 |
| PE20110903A1 (es) | 2012-01-19 |
| DK2412714T3 (en) | 2016-02-01 |
| ES2562637T9 (es) | 2017-05-30 |
| BRPI1013548B1 (pt) | 2020-06-09 |
| JP2012521408A (ja) | 2012-09-13 |
| CA2754154A1 (en) | 2010-09-30 |
| ES2562637T3 (es) | 2016-03-07 |
| HUE027480T2 (en) | 2016-09-28 |
| EP2412714B1 (en) | 2015-11-11 |
| BRPI1013548A2 (pt) | 2016-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013548B8 (pt) | método de purificação industrial de ficotoxinas biologicamente ativas | |
| BR112017020604A2 (pt) | cepa de paenibacillus inovadora, compostos antifúngicos e métodos para seu uso | |
| AR106800A1 (es) | Composiciones que comprenden cepas bacterianas | |
| WO2008118907A3 (en) | Lateral spinous process spacer | |
| BR112013011263A2 (pt) | "composição nematicida, e método para controlar nematódeos" | |
| BRPI0712816B8 (pt) | compostos de pirrolpirimidina e seus usos | |
| WO2010033740A3 (en) | Shredder for mechanical disruption by gentle controlled compressive rotation | |
| CR20120120A (es) | Metodos para el tratamiento de un sarcoma utilizando un cambiador epimetabolico (coenzima q10) | |
| IN2015DN01010A (pt) | ||
| PL2477639T3 (pl) | Ekstrakt roślinny, zawierające go kompozycje, sposób jego ekstrakcji i jego zastosowania | |
| UA109255C2 (ru) | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 | |
| BRPI0914348A2 (pt) | Método para melhorar a saúde de uma planta cultivada, usos de pelo menos um composto, fruto e semente | |
| WO2008011538A3 (en) | Methods of using flavonoids to enhance memory | |
| IN2014DN08554A (pt) | ||
| MX2011006049A (es) | Extracto citrico de alto contenido de flavonoides (hesperidina, narirutina, didimina). | |
| DK2470520T3 (da) | Chromonderivater, fremgangsmåde til fremstilling af disse og deres terapeutiske anvendelser | |
| BRPI0920639A2 (pt) | Unidade de tratamento de ácido concentrado, planta de sistema de separação de fase, e, métodos de tratamento de ácido concentrado, e para conversão do sistema de separação de fase para recurso botânico | |
| PE20210463A1 (es) | Uso de composiciones que contienen streptomyces melanosporofaciens agl225 en el control de enfermedades de las plantas | |
| WO2011054929A3 (fr) | Procede de production de triptolide | |
| MX2010007810A (es) | Coposicion que contiene capsicum para tratar un trastorno de la piel. | |
| PH12014500596A1 (en) | Plant steroids and uses thereof | |
| BRPI0821222A2 (pt) | Método e usina para produção de vácuo em uma coluna de destilação de petróleo | |
| EP2519244A4 (en) | EXTRACT FROM THE CHINESE VEGETABLE TREE OF SUPERCRITIC FLUIDS FOR THE TREATMENT OF DIABETES AND METABOLISM DISEASES AND METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | |
| MX2018004489A (es) | Extracto de agavaceae que comprende saponinas esteroidales y su uso para tratar y/o prevenir patologías relacionadas con desórdenes metabólicos. | |
| ES2369569T8 (es) | Método para producir cepas rugosas de bacterias y sus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |